Cargando…

Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer

The aim of the present study was to find out whether increasing malignancy of prostate carcinoma correlates with an overall increase of loss of heterozygosity (LOH), and whether LOH typing of microdissected tumour areas can help to distinguish between multifocal or clonal tumour development. In 47 c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hügel, A, Wernert, N
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362403/ https://www.ncbi.nlm.nih.gov/pubmed/10027329 http://dx.doi.org/10.1038/sj.bjc.6690087

Ejemplares similares

Dissecting Loss of Heterozygosity (LOH) in Neurofibromatosis Type 1-Associated Neurofibromas: Importance of Copy Neutral LOH
por: Garcia-Linares, Carles, et al.
Publicado: (2011)

Direct Inference of SNP Heterozygosity Rates and Resolution of LOH Detection
por: Li, Xiaohong, et al.
Publicado: (2007)

Vitamin B6 Deficiency Promotes Loss of Heterozygosity (LOH) at the Drosophila warts (wts) Locus
por: Gnocchini, Eleonora, et al.
Publicado: (2022)

Single Nucleotide Polymorphism (SNP)-Based Loss of Heterozygosity (LOH) Testing by Real Time PCR in Patients Suspect of Myeloproliferative Disease
por: Huijsmans, Cornelis J. J., et al.
Publicado: (2012)

In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin’s lymphoma (NHL)
por: Aya-Bonilla, Carlos, et al.
Publicado: (2014)

Loss of heterozygosity at 7p in Wilms' tumour development
por: Powlesland, R M, et al.
Publicado: (2000)

Loss of heterozygosity is related to p53 mutations and smoking in lung cancer
por: Zienolddiny, S, et al.
Publicado: (2001)

Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
por: Sheu, J-C, et al.
Publicado: (1999)

Loss of Heterozygosity Drives Clonal Diversity of Phytophthora capsici in China
por: Hu, Jian, et al.
Publicado: (2013)

Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236
por: Staratschek-Jox, A, et al.
Publicado: (2001)

Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers
por: Muzumdar, Mandar Deepak, et al.
Publicado: (2016)

European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables
por: Launonen, V, et al.
Publicado: (1999)

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer
por: Oesterreich, S, et al.
Publicado: (2001)

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder
por: Edwards, J, et al.
Publicado: (2001)

In Reply to Loh and Lin:
por: Vaduganathan, Muthiah, et al.
Publicado: (2014)

Investigation of Cervical Tumor Biopsies for Chromosomal Loss of Heterozygosity (LOH) and Microsatellite Instability (MSI) at the HLA II Locus in HIV-1/HPV Co-infected Women
por: Chambuso, Ramadhani, et al.
Publicado: (2019)

LOH Detected by Microsatellite Markers Reveals the Clonal Origin of Recurrent Laryngeal Squamous Cell Carcinoma
por: Cui, Zhaoyang, et al.
Publicado: (2014)

Loss of heterozygosity of TRIM3 in malignant gliomas
por: Boulay, Jean-Louis, et al.
Publicado: (2009)

High-Resolution Genome-Wide Analysis of Irradiated (UV and γ-Rays) Diploid Yeast Cells Reveals a High Frequency of Genomic Loss of Heterozygosity (LOH) Events
por: St. Charles, Jordan, et al.
Publicado: (2012)

Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
por: Burt, E C, et al.
Publicado: (2000)

Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival
por: Ragnarsson, G, et al.
Publicado: (1999)

Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers
por: Jernvall, P, et al.
Publicado: (1999)

Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer
por: Benachenhou, N, et al.
Publicado: (1999)

Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3
por: Cleton-Jansen, A-M, et al.
Publicado: (1999)

How clonal are clones? A quest for loss of heterozygosity during asexual reproduction in Daphnia magna
por: Dukić, Marinela, et al.
Publicado: (2019)

Clonal polymorphism and high heterozygosity in the celibate genome of the Amazon molly
por: Warren, Wesley C., et al.
Publicado: (2018)

Life Origination Hydrate Hypothesis (LOH-Hypothesis)
por: Ostrovskii, Victor, et al.
Publicado: (2012)

Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations
por: Gonzalez, R, et al.
Publicado: (1999)

Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis
por: Sunpaweravong, Somkiat, et al.
Publicado: (2019)

Clonal evidence for the development of neuroblastoma with extensive copy‐neutral loss of heterozygosity arising in a mature teratoma
por: Ono, Rintaro, et al.
Publicado: (2021)

Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head andeck, despite loss of heterozygosity at this locus
por: Snaddon, J, et al.
Publicado: (2001)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

An integrated Bayesian analysis of LOH and copy number data
por: Rancoita, Paola MV, et al.
Publicado: (2010)

Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene
por: Liscia, D S, et al.
Publicado: (1999)

Polyploidy as an Adaptation against Loss of Heterozygosity in Cancer
por: Archetti, Marco
Publicado: (2022)

2022 ISCB Overton Prize: Po-Ru Loh
por: Fogg, Christina, et al.
Publicado: (2022)

Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer
por: ELTAHIR, HUDA A., et al.
Publicado: (2012)

Targeting loss of heterozygosity for cancer-specific immunotherapy
por: Hwang, Michael S., et al.
Publicado: (2021)

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons
por: Green, Michael R, et al.
Publicado: (2010)

Loss of heterozygosity of the oestrogen receptor gene in breast cancer.
por: Iwase, H., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_ubimjmu42hth7tp63bcse1rjsd